StockCIK 1867096

Xeris Biopharma Holdings, Inc. (XERS): Insider Trades and Fund Holdings

In the past 12 months, Xeris Biopharma Holdings, Inc. insiders reported 0 open-market purchases worth $0 and 7 sales worth $906K; 7 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$906KSold by insiders, 12 months

1Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144) and fund moves in the past year, newest first.

Oct 1, 2026Insider saleSee Remarks Beth Hecht sold $156,792 under a 10b5-1 plan
Oct 1, 2026Insider saleSee Remarks Kevin McCulloch sold $141,120 under a 10b5-1 plan
Oct 1, 2026Insider saleSee Remarks Steven Pieper sold $47,037 under a 10b5-1 plan
Oct 1, 2026Planned saleBETH HECHT (officer) filed notice to sell about $159,327 around Oct 1, 2026
Sep 28, 2026Insider saleSee Remarks Kevin McCulloch sold $250,000 under a 10b5-1 plan
Sep 28, 2026Planned saleKEVIN MCCULLOCH (officer) filed notice to sell about $637,000 around Sep 28, 2026
Sep 1, 2026Insider saleSee Remarks Beth Hecht sold $141,434 under a 10b5-1 plan
Sep 1, 2026Insider saleSee Remarks Kevin McCulloch sold $127,308 under a 10b5-1 plan
Sep 1, 2026Insider saleSee Remarks Steven Pieper sold $42,500 under a 10b5-1 plan
Jun 30, 2026FundRenaissance Technologies cut 85% in Q2 2026 (13F filed Aug 13, 2026)

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 2, 2026.

Recent XERS insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 2	Oct 1	Beth HechtSee Remarks	See Remarks	▼ SELL10b5-1	16,666	9.41	$157K	−1.5%	Form 4 ↗
Oct 2	Oct 1	Kevin McCullochSee Remarks	See Remarks	▼ SELL10b5-1	15,000	9.41	$141K	−0.9%	Form 4 ↗
Oct 2	Oct 1	Steven PieperSee Remarks	See Remarks	▼ SELL10b5-1	5,000	9.41	$47K	−0.4%	Form 4 ↗
Sep 29	Sep 28	Kevin McCullochSee Remarks	See Remarks	▼ SELL10b5-1	25,000	10.00	$250K	−1.5%	Form 4 ↗
Sep 1	Sep 1	Beth HechtSee Remarks	See Remarks	▼ SELL10b5-1	16,666	8.49	$141K	−1.5%	Form 4 ↗
Sep 1	Sep 1	Kevin McCullochSee Remarks	See Remarks	▼ SELL10b5-1	15,000	8.49	$127K	−0.9%	Form 4 ↗
Sep 1	Sep 1	Steven PieperSee Remarks	See Remarks	▼ SELL10b5-1	5,000	8.50	$43K	−0.4%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Bought	Sells	Sold	Latest
Beth Hecht	See Remarks	$0	2	$298K	Oct 2, 2026
Kevin McCulloch	See Remarks	$0	3	$518K	Oct 2, 2026
Steven Pieper	See Remarks	$0	2	$90K	Oct 2, 2026

Buybacks and executive pay

Year	CEO pay reported	CEO pay "actually paid"	Value of $100 invested
2025	$5.04M	$12.0M	n/a
2023	$2.14M	$3.46M	n/a

From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.

Tracked funds that report XERS

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	67,337	$533K	0.00%	▼ −85.1%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →